Status:
ACTIVE_NOT_RECRUITING
COLON-MD: Colon Cancer Longitudinal Study
Lead Sponsor:
Baylor Research Institute
Collaborating Sponsors:
Baylor University
Conditions:
Colon Cancer
Eligibility:
All Genders
18-79 years
Brief Summary
The goal of this proposal is to identify how the composition of the gut microbiome and diet interact to impact chemotherapy-induced diarrhea incidence and severity.
Detailed Description
In this longitudinal observational study patients will supply samples of their gut microbiome prior to scheduled colonoscopy or surgery along with dietary intake and blood samples; the relative abunda...
Eligibility Criteria
Inclusion
- Colon cancer diagnosis
- Age \>18 and \< or equal to 79.
- Ability to perform informed consent
- FOLFOX treatment expected
Exclusion
- Not Pregnant
- Does not have Lynch syndrome or FAP diagnosis.
- Inability to perform inform consent
- inability to comply with follow up program
- history of prior colon cancer diagnosis
- previous treatment with antibiotics in the last month.
- previous bowel resection.
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2025
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT04751448
Start Date
February 1 2021
End Date
February 1 2025
Last Update
August 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baylor Research Institute
Temple, Texas, United States, 76508